What does “Emend dose IV” mean?
“Emend” is aprepitant. “IV” usually means the drug is being given intravenously (through a vein) rather than by mouth. Exact dosing depends on whether it’s being used for chemotherapy-induced nausea and vomiting (CINV) and what other anti-nausea medicines are included in the regimen.
What is the IV dose of Emend (aprepitant)?
Standard prescribing guidance for aprepitant IV uses a single fixed dose during the treatment period:
- Emend IV is given as an intravenous dose of 130 mg on Day 1, with follow-on aprepitant treatment typically continued as part of a multi-day antiemetic regimen.
Your final dose may change based on the full protocol (for example, whether dexamethasone and a 5-HT3 antagonist are being used, and whether the regimen is for highly emetogenic vs moderately emetogenic chemotherapy).
How is Emend IV usually scheduled with other CINV drugs?
In common CINV protocols, Emend (aprepitant) works alongside:
- a corticosteroid such as dexamethasone
- a 5-HT3 antagonist such as ondansetron or palonosetron
The timing matters because Day-1 dosing is typically when Emend IV is used, with continuation on subsequent days using oral aprepitant formulations.
What factors change the IV dose?
Dose and regimen can vary if:
- the chemotherapy is “highly” vs “moderately” emetogenic
- the prescriber is using a specific labeled combination regimen
- drug interactions are present (aprepitant can affect metabolism of other medicines)
If you tell me the context, I can give the exact dose regimen
To ensure the correct “Emend dose IV,” tell me:
1) Is it for chemotherapy-induced nausea/vomiting (CINV)? If yes, highly or moderately emetogenic?
2) What other meds are included (dexamethasone and which 5-HT3 drug)?
3) Patient age and whether this is adult or pediatric dosing (if pediatric, which age)?
Sources